Register now to attend the ESC Congress 2026
- Date: Friday 28 August – Monday 31 August 2026
- Location: Munich and online
UK Biobank is excited to be presenting at and attending European Society of Cardiology (ESC) Congress 2026 in Munich.
ESC Congress 2026 brings together the global cardiology community to share breakthrough research, gain practical insights, and connect with peers and experts shaping the future of cardiovascular health.
Session
UK Biobank: a multimodal resource for cardiovascular discovery at scale
- Date: Saturday 29 August 2026
- Time: 5:30pm – 6:30pm
- Location: Kyiv – Hall B1
Experience how the UK Biobank’s latest advances are reshaping cardiovascular research.
This event highlights the power of integrating large‑scale imaging, proteomics, genomics and rich phenotypic data to uncover new disease mechanisms, improve risk prediction across diverse populations and accelerate biomarker and therapeutic target discovery.
With applications spanning hypertension, cardio‑renal‑metabolic disease, sleep health and sex‑specific cardiovascular risk, it’s a chance to see how multimodal data is driving the future of heart health.
Chairpersons
Dr Lewandowski specializes in early cardiovascular changes in at-risk populations. His research uses advanced imaging and deep phenotyping to study the long-term effects of early life conditions. He joined UK Biobank in 2024 to help shape its scientific strategy, including the Brain Health study.
Professor Bernard Keavney is a Clinical Academic Cardiologist and Human Geneticist. He currently serves as Professor of Cardiovascular Medicine at The University of Manchester, funded by the British Heart Foundation.
Agenda
-
5:30pm
Updates and future direction of UK Biobank
Professor Sir Rory Collins, UK Biobank
-
5:40pm
Proteomics at scale: opportunities for target discovery
-
5:50pm
The impact of sleep on cardiovascular-kidney-metabolic health
Professor Eva Schernhammer, University of Vienna
-
6pm
Redefining cardiovascular risk in women
Dr Michael Honigberg, Massachusetts General Hospital
-
6:10pm
Hypertension-associated organ-disease phenotypes
Dr Winok Lapidaire, University of Oxford
-
6:20pm
UK Biobank: a multimodal resource for cardiovascular discovery at scale
Q&A with the audience
Speakers
Sir Rory Collins is Emeritus Professor of Medicine & Epidemiology at University of Oxford and has led UK Biobank since its inception. He is known for pioneering large-scale epidemiological studies and clinical trials that have transformed cardiovascular disease prevention. He was knighted in 2011 for services to science.
Eva Schernhammer is Professor and Chair of the Department of Epidemiology at the Medical University of Vienna, Adjunct Professor at the Department of Epidemiology at the Harvard T.H. Chan School of Public Health and Investigator at Mass General Brigham in Boston.
Dr Honigberg is a cardiologist and researcher at Massachusetts General Hospital and an Assistant Professor of Medicine at Harvard Medical School. He specialises in heart disease prevention and heart disease in women.
Dr Winok Lapidaire is a Principal Investigator in the Cardiovascular Medicine Division, University of Oxford. Her research focuses on the effect of high blood pressure on the brain with a particular interest for the effects of high blood pressure during pregnancy.
Learn more about UK Biobank
UK Biobank is the world’s most comprehensive dataset of biological, health and lifestyle information. Learn more about who we are.
UK Biobank plays a vital role in advancing modern medicine and treatment through the UK Biobank Research Analysis Platform (UKB-RAP), a restricted, sophisticated and user-friendly cloud-based tool.